T. Rowe Price Investment Management, Inc. Insmed Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Insmed Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,476,948 shares of INSM stock, worth $150 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,476,948
Previous 1,982,707
25.51%
Holding current value
$150 Million
Previous $137 Million
17.69%
% of portfolio
0.07%
Previous 0.08%
Shares
11 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.86 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.56 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.45 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$1.31 Billion0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$731 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $13.8B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...